All Access Articles |
- ATAI Life Sciences Raises $149.5M in Public Offering | 2025-10-21 | PHARMACEUTICAL
- ATAI Life Sciences Prices Offering, Shares Surge 17.7% | 2025-10-20 | PHARMACEUTICAL
- ATAI Life Sciences' BPL-003 Nasal Spray Gets FDA Breakthrough Designation | 2025-10-17 | PHARMACEUTICAL
- Beckley Psytech Interim Financials Show Operating Loss Increase | 2025-10-13 | PHARMACEUTICAL
- ATAI Life Sciences Reports Increased Losses in Financial Statements | 2025-10-12 | PHARMACEUTICAL
- Beckley Psytech's Financial Losses Double | 2025-10-11 | PHARMACEUTICAL
- ATAI Life Sciences Reports Operating Losses and Decrease in Share Price | 2025-09-30 | PHARMACEUTICAL
- ATAI Life Sciences Reports Positive Results for BPL-003 in Treatment-Resistant Depression | 2025-09-24 | PHARMACEUTICAL
- ATAI Life Sciences Reports Positive Phase 2a Data for Novel Antidepressant BPL-003 | 2025-09-23 | PHARMACEUTICAL
- ATAI Life Sciences Reports Positive Phase 2b Results | 2025-08-14 | PHARMACEUTICAL
- ATAI Life Sciences Reports Positive Phase 2b Results in Treatment-Resistant Depression | 2025-07-01 | PHARMACEUTICAL